Clinical conferences for physicians: Who sets the agenda?

Clinical conferences are widely used to support physician education and collaboration. These events typically involve physicians presenting cases and sharing recent developments in their fields. While the value of such conferences is often linked to peer-to-peer learning and quality improvement, the role of pharmaceutical companies in organizing and funding these events raises concerns. Prior research has shown that such conferences can serve as platforms for knowledge exchange. However, recent trends suggest that pharmaceutical sponsorship may shift the focus of these events. This gap motivated an investigation into who organizes these conferences and how they are structured.

This study aimed to explore the organization and structure of clinical conferences attended by physicians. Specifically, the researchers sought to determine who attended these events, who presented, and which organizations were responsible for organizing them. The motivation stemmed from concerns about the influence of pharmaceutical companies on medical education. By analyzing printed invitations received by a single physician over two years, the study aimed to reveal patterns in conference frequency, sponsorship, and speaker involvement. The goal was to understand how these events are structured and who benefits from them.

The study used a descriptive approach, analyzing printed invitations received by a primary care physician in Kazan over two years. The invitations were collected and categorized by organizer, speaker, and sponsorship. Researchers examined the frequency of conferences, the months in which they occurred, and the types of events. They also noted which organizations issued invitations and whether pharmaceutical companies were involved. The data included details such as speaker affiliations, event timing, and promotional content. Researchers compared the number of conferences per month and identified patterns in sponsorship and speaker involvement.

Over two years, the physician received 47 printed invitations to clinical conferences. November had the highest number of events in both years. Forty-one conferences were sponsored by pharmaceutical companies, either alone or in partnership with medical institutions. Four conferences were organized by public health agencies, with official orders from the Health Department. Seventeen conferences occurred during official working hours. Pharmaceutical logos and drug advertisements were present on invitations. Twenty conferences listed guest lecturers from Moscow and St. Petersburg. Opinion leaders often spoke at multiple events per month. Dinner and lunch invitations were included in some conferences.

The findings suggest that pharmaceutical companies play a major role in organizing clinical conferences. These events often occur during working hours and include promotional content. Keynote speakers were primarily opinion leaders from major medical institutions. Governmental agencies also participated in organizing some conferences. The repetitive involvement of certain speakers raises questions about the independence of these events. The study highlights the influence of pharmaceutical sponsorship on medical education. The authors propose that the structure of these conferences may be shaped more by commercial interests than by educational goals. These findings trace directly to the authors' analysis of the invitation data.